Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer

by Chen, Jian, Tang, Huamei, Wu, Zehua, Zhou, Chongzhi, Jiang, Tao, Xue, Yingming, Huang, Guoyu, Yan, Dongwang, Peng, Zhihai
Published 2013

Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer

by Wang, Jingtao, Cui, Feifei, Wang, Xiao, Xue, Yingming, Chen, Jian, Yu, Yang, Lu, Huijun, Zhang, Meng, Tang, Huamei, Peng, Zhihai
Published 2015

Zinc-α-2-Glycoprotein: A Candidate Biomarker for Colon Cancer Diagnosis in Chinese Population

by Xue, Yingming, Yu, Fudong, Yan, Dongwang, Cui, Feifei, Tang, Huamei, Wang, Xiaoliang, Chen, Jian, Lu, Huijun, Zhao, Senlin, Peng, Zhihai
Published 2014

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer

by Zhang, Meng, Cui, Feifei, Lu, Su, Lu, Huijun, Xue, Yingming, Wang, Jingtao, Chen, Jian, Zhao, Senlin, Ma, Shaofei, Zhang, Yu, Yu, Yang, Peng, Zhihai, Tang, Huamei
Published 2015

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

by Chen, Jian, Lu, Huijun, Yan, Dongwang, Cui, Feifei, Wang, Xiaoliang, Yu, Fudong, Xue, Yingming, Feng, Xiaodong, Wang, Jingtao, Wang, Xiao, Jiang, Tao, Zhang, Meng, Zhao, Senlin, Yu, Yang, Tang, Huamei, Peng, Zhihai
Published 2014

DDA1 promotes stage IIB–IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling

by Zhao, Senlin, Tang, Huamei, Yan, Dongwang, Fan, Junwei, Sun, Hongcheng, Wen, Yugang, Yu, Fudong, Cui, Feifei, Zhang, Dongyuan, Xue, Yingming, Liu, Chenchen, Yue, Ben, Chen, Jian, Wang, Jingtao, Wang, Xiao, Zhang, Meng, Yu, Yang, Jiang, Weiliang, Liu, Xisheng, Mi, Yushuai, Zhou, Zongguang, Qin, Xuebin, Peng, Zhihai
Published 2016